Atrial Fibrillation|https://phgkb.cdc.gov/GAPPKB/phgHome.do|Atrial Fibrillation

https://phgkb.cdc.gov/GAPPKB/phgHome.do




Last Posted: May 01, 2017

---

• Circulating MicroRNAs as Potential Biomarkers of Atrial Fibrillation.  
  da Silva Ananília Medeiros Gomes et al. BioMed research international 2017 7804763
• Genetic Risk Prediction of Atrial Fibrillation.  
  Lubitz Steven A et al. Circulation 2017 Apr (14) 1311-1320
• Update about atrial fibrillation genetics.  
  Pérez-Serra Alexandra et al. Current opinion in cardiology 2017 Feb
• Proteomics of Atrial Fibrillation: Evolving From a Coarse Understanding to a Fine Phenotype.  
  Hyman Matthew C et al. JAMA cardiology 2017 Mar
• Proteomics of Atrial Fibrillation- Evolving From a Coarse Understanding to a Fine Phenotype  
  C Hyman, JAMA Cardiology, March 29, 2017
• Update on hypertrophic cardiomyopathy and a guide to the guidelines.  
  Sen-Chowdhry Srijita et al. Nature reviews. Cardiology 2016 Nov 13(11) 651-675
• Evaluation of a New Genetic Epidemiology Resource: The Intermountain Genealogy Registry.  
  Knight Stacey et al. Human heredity 2016 Jul 81(1) 1-10
• Genetic Investigation Into the Differential Risk of Atrial Fibrillation Among Black and White Individuals  
  JD Roberts et al, JAMA Cardiology, June 22, 2016
• The “Double” Paradox of Atrial Fibrillation in Black Individuals  
  TS Stamos et al, JAMA Cardiology, June 22, 2016
• Cost-effectiveness of pharmacogenetic-guided dosing of warfarin in the United Kingdom and Sweden.  
  Verhoef T I et al. The pharmacogenomics journal 2016 Jun
• Economic evaluation of pharmacogenomic-guided warfarin treatment for elderly Croatian atrial fibrillation patients with ischemic stroke.  
  Mitropoulou Christina et al. Pharmacogenomics 2015 Jan 16(2) 137-48
• Genetic risk for atrial fibrillation could motivate patient adherence to warfarin therapy: a cost effectiveness analysis.  
  Shiffman Dov et al. BMC cardiovascular disorders 2015 15(1) 104
• Universal versus genotype-guided use of direct oral anticoagulants in atrial fibrillation patients: a decision analysis.  
  You Joyce Hs et al. Pharmacogenomics 2015 Jul 31. 1-12
• Clinical Benefit of American College of Chest Physicians Versus European Society of Cardiology Guidelines for Stroke Prophylaxis in Atrial Fibrillation. 
  Andrade Ambar A et al. J Gen Intern Med 2015 May 7.
• Common and rare variants in SCN10A modulate the risk of atrial fibrillation.  
  Jabbari Javad et al. Circ Cardiovasc Genet 2015 Feb (1) 64-73
• Common genetic variants and response to atrial fibrillation ablation.  
  Shoemaker M Benjamin et al. Circ Arrhythm Electrophysiol 2015 Apr (2) 296-302

more